Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin vs Loratadine for Uremic Pruritus in CKD
NCT05750875Phase 4Completed
- Sponsor
- King Edward Medical University
- Start
- May 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gabapentin in uremic pruritus (2 arms), sponsored by King Edward Medical University. Primary endpoint: Mean reduction in pruritus score on Numerical Rating Scale at 4 weeks. Started May 2022; status: completed.
02
Drugs
gabapentin
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT05750875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05750875.